Jolavi | Midodrine Tablets | Inramed | Gutron | Details, Costing & Pricing 

Jolavi | Midodrine Tablets | Inramed | Gutron is used to treat low blood pressure (hypotension). It is prescribed to patients who experience dizziness due to low blood pressure while standing up suddenly from sitting or lying position.This medicine causes blood arteries to constrict, resulting in an increase in blood pressure.

This medicine is usually prescribed to be taken during daytime when people stand most often.It should not be taken if you plan to lie down for an extended period of time after the dose. You should always take this medicine as advised by the doctor and should never discontinue it without consulting the doctor. While using this medicine, keep a close eye on your blood pressure.

Headache, nausea, rash, and difficulty urinating are all common side effects of this medicine. If these side effects affect you, talk to your doctor. It can also cause supine hypertension, which is when your blood pressure rises while you're lying down.

Before taking this medicine, it is better to let your doctor know if you are suffering from any kidney or liver disease. Pregnant women and breastfeeding moms should also consult a doctor before taking it. You must tell your doctor about all other medications you are taking in addition to this one. Your doctor may ask for monitoring of kidney and liver function before and during the treatment with this medicine.

USES OF JOLAVI TABLET

Jolavi Midodrine Tablet is used to treat low blood pressure.

BENEFITS OF JOLAVI TABLET

In Low blood pressure

Jolavi Midodrine Tablet is used in adults and children to relieve low blood pressure that may occur due to sudden change in posture from lying to sitting or standing up, during an operation or after an injury.This medicine helps to replace blood pressure to normal levels, preventing any rapid drops or potentially significant consequences that could occur as a result of low blood pressure.

SIDE EFFECTS

TMost side effects are modest and will subside as your body adjusts to the medicine. If they persist or cause you concern, speak with your doctor.

Common side effects of Jolavi

• Headache
• Nausea
• Rash
• Difficulty in urination

HOW TO USE JOLAVI TABLET

Follow your doctor's dosage and duration directions for this medicine. Swallow it as a whole. Do not chew, crush or break it. Jolavi Tablets can be taken with or without food, however it is best to take them at the same time every day. This drug should be taken during the day or when you will be standing for significant periods of time. Avoid taking it when you have to lie down for long hours and do not discontinue taking it without doctor’s advice.

HOW JOLAVI TABLET WORKS

Jolavi Tablet is an alpha-adrenergic agonist. It works by activating specific receptors on blood vessels. This causes blood arteries to constrict, raising blood pressure.

SAFETY ADVISE

Alcohol

CONSULT YOUR DOCTOR

It is unknown whether it is safe to consume alcohol with Jolavi Tablet. Please consult your doctor.

Pregnancy

CONSULT YOUR DOCTOR

The use of Jolavi Tablet during pregnancy may be problematic. Animal research have shown harmful effects on the growing foetus, despite the lack of human studies. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

Breast feeding

CONSULT YOUR DOCTOR

Jolavi Tablet is probably unsafe to use during breastfeeding. The drug may transfer into breastmilk and harm the newborn, according to limited human research.

Driving

CONSULT YOUR DOCTOR

It is unknown whether Jolavi Tablet alters the ability to drive. If you have any symptoms that impair your ability to concentrate or respond, don't drive.

Kidney

CONSULT YOUR DOCTOR

On the use of Jolavi Tablet in patients with kidney illness, there is minimal information. Please consult your doctor.

Liver

CONSULT YOUR DOCTOR

On the use of Jolavi Tablet in patients with liver illness, there is minimal information. Please consult your doctor.

QUICK TIPS

• Take Jolavi Tablet at least 4 hours before bedtime to avoid the risk of high blood pressure at night time. 
• While using this medicine, keep a close eye on your blood pressure.
• If you have a history of prostate disease or a blood circulation problem, tell your doctor.
• If you experience chest pain, palpitations, headache, shortness of breath, or impaired vision, call your doctor right away.
• If you are pregnant, planning a pregnancy, or breastfeeding, tell your doctor.

FAQs

Q. Does Jolavi Tablet raise blood pressure?

Yes, Jolavi Tablet may cause high blood pressure when you are lying flat on your back (supine hypertension). This medicine should only be used by people whose low blood pressure affects their day-to-day life and in people who could not be treated successfully with other therapies.

Q. Does Jolavi Tablet affect heart rate?

Jolavi Tablet may cause a mild decrease in heart rate. It should be used cautiously when using it with other medicines (beta blockers, digitalis, etc.) which can further slow down the heart rate. Patients should be monitored if they experience symptoms which are suggestive of slow heart rate.

Q. Can I lie down after taking Jolavi Tablet?

You should not lie down immediately after taking Jolavi Tablet because of the risk of supine hypertension (high blood pressure that occurs when you are lying flat on your back). As a result, the last daily dose should be taken at least 4 hours before night. You can reduce the risk of supine hypertension occurring during the night by elevating the head.

Q. Does Jolavi Tablet work immediately?

Jolavi Tablet takes about 1 hour to show its effects. However, the action lasts for a short time only; the effect persists for about 2-3 hours.

Q. How do I take Jolavi Tablet?

Jolavi Tablet should be taken exactly as your doctor prescribes. Jolavi Tablet is taken orally with or without food. Swallow the tablet as a whole with a glass of water. Usually, it is advised to take the medicine three times a day (morning, midday, and late afternoon [before 6PM]) with a gap of at least 3 hours. Take the last daily dose of Jolavi Tablet before an evening meal and at least 4 hours before bedtime.

Q. Who should not take Jolavi Tablet?

Patients with an allergy to any component of the medicine, serious cardiac disease, exceptionally slow heart rate, high blood pressure, or diseases that cause artery tightening should not take Jolavi Tablet. Along with that, treatment with Jolavi Tablet should be avoided if the patient has enlarged prostate gland, urinary retention (when the bladder can’t empty properly), pheochromocytoma (tumour of the adrenal medulla), acute or severe kidney disease, overactive thyroid, poor vision as a result of diabetes, and narrow-angle glaucoma (elevated pressure in the eye).

Q. Is any monitoring required during Jolavi Tablet treatment?

Before you start using Jolavi Tablet, you should check your blood pressure and have your kidney and liver function tests done. Once you begin the treatment, keep a constant track of your blood pressure and heart rate, especially after lying down.

Q. How will I know that I have developed supine hypertension?

Symptoms of supine hypertension include chest pain, palpitations, shortness of breath, headache, and blurred vision. Tell your doctor right away if you get these symptoms. The doctor may reduce the dose of Jolavi Tablet or may discontinue treatment if the symptoms persists.

Q. Can I take metoprolol with Jolavi Tablet?

Using Jolavi Tablet and metoprolol together can make your heart rate considerably slow. Hence, you need to be careful while using both together. If you experience slow pulse, dizziness and fainting, inform your doctor, as the dose of these medicines may need to be modified.

For more information, visit-

Jolavi Midodrine Tablet: Know the Uses, Benefits, Side Effects

REFERENCES:

1. Westfall TC, WestfallIn DP. Adrenergic Agonists and Antagonists. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 295.
2. Biaggioni I, Robertson D. Adrenoreceptor Agonists & Sympathomimetic Drugs. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 139.
3. Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 915-16.
4. Central Drugs Standard Control Organisation (CDSCO). [Accessed 19 Mar. 2019] (online) Available from: